Bonafide Health, LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
12
Ending by 2030
Jun 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 30, 2027The maintenance fee for Multiple Unit Dosage Form Having a Therapeutic Agent in Combination with a Nutritional Supplement (US 10,363,222) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Maca Compositions and Methods of Use (US 11,752,186) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 2 fees due Apr 10 to 30, 2027 · next Apr 10
- 2 fees due Jun 26, 2027
- 1 fee due Jul 2, 2027The maintenance fee for Curcumin Compositions and Methods of Use as an NK3 Antagonist (US 11,857,594) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,005,637 | Multiple Unit Dosage Form Having a Therapeutic Agent in Combination with a Nutritional Supplement In force · High confidence | In force | High confidence | |
| US 9,421,170 | Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement In force · USPTO record | In force | USPTO record | |
| US 10,363,222 | Multiple Unit Dosage Form Having a Therapeutic Agent in Combination with a Nutritional Supplement In force · Medium confidence | In force | Medium confidence | |
| US 11,241,388 | Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement In force · USPTO record | In force | USPTO record | |
| US 11,801,224 | Multiple Unit Dosage Form Having A Therapeutic Agent In Combination With A Nutritional Supplement In force · Low confidence | In force | Low confidence | |
| US 11,850,308 | Multiple Unit Dosage Form Having A Therapeutic Agent In Combination With A Nutritional Supplement In force · Medium confidence | In force | Medium confidence | |
| US 12,274,791 | Multiple Unit Dosage Form Having A Therapeutic Agent In Combination With A Nutritional Supplement In force · Medium confidence | In force | Medium confidence | |
| US 8,586,061 | Multiple Unit Dosage Form Having a Therapeutic Agent in Combination with a Nutritional Supplement In force · High confidence | In force | High confidence | |
| US 8,329,208 | Pharmacokinetics of S-adenosylmethionine formulations In force · USPTO record | In force | USPTO record | |
| US 8,580,296 | Pharmacokinetics of S-adenosylmethionine formulations In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
8 pending · 1 abandoned · 1 no status recorded